Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Polymorphisms in PARK2 and MRPL37 are associated with higher risk of recurrent venous thromboembolism in a sex-specific manner.

Sundquist K, Ahmad A, Svensson PJ, Zöller B, Sundquist J, Memon AA.

J Thromb Thrombolysis. 2018 Aug;46(2):154-165. doi: 10.1007/s11239-018-1662-x.

PMID:
29671165
2.

Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence.

Sundquist K, Wang X, Svensson PJ, Sundquist J, Hedelius A, Larsson Lönn S, Zöller B, Memon AA.

Thromb Haemost. 2015 Nov 25;114(6):1156-64. doi: 10.1160/TH15-01-0031. Epub 2015 Aug 6.

PMID:
26245493
3.

PLA2 polymorphism of platelet glycoprotein IIb/IIIa but not Factor V Leiden and prothrombin G20210A polymorphisms is associated with venous thromboembolism and more recurrent events in central Iran.

Pourgheysari B, Boroujeni HR, Hasheminia AM, Drees F.

Blood Coagul Fibrinolysis. 2013 Jul;24(5):471-6. doi: 10.1097/MBC.0b013e32835e4260.

PMID:
23358226
4.

Gender-related differences in the outcome of patients with venous thromboembolism and thrombophilia.

Tzoran I, Papadakis E, Brenner B, Valle R, López-Jiménez L, García-Bragado F, Riera-Mestre A, Villalobos A, Quintavalla R, Monreal M; RIETE Investigators.

Thromb Res. 2017 Mar;151 Suppl 1:S11-S15. doi: 10.1016/S0049-3848(17)30060-9.

PMID:
28262227
5.

Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form.

Sveinsdottir SV, Saemundsson Y, Isma N, Gottsäter A, Svensson PJ.

Thromb Res. 2012 Sep;130(3):467-71. doi: 10.1016/j.thromres.2012.03.020. Epub 2012 Apr 17.

PMID:
22512897
6.

Fat mass and obesity-associated gene rs9939609 polymorphism is a potential biomarker of recurrent venous thromboembolism in male but not in female patients.

Ahmad A, Memon AA, Sundquist J, Svensson PJ, Zöller B, Sundquist K.

Gene. 2018 Mar 20;647:136-142. doi: 10.1016/j.gene.2018.01.013. Epub 2018 Jan 9.

7.
8.

Role of family history of venous thromboembolism and thrombophilia as predictors of recurrence: a prospective follow-up study.

Sundquist K, Sundquist J, Svensson PJ, Zöller B, Memon AA.

J Thromb Haemost. 2015 Dec;13(12):2180-6. doi: 10.1111/jth.13154. Epub 2015 Oct 29.

9.

Thrombomodulin gene c.1418C>T polymorphism and risk of recurrent venous thromboembolism.

Ahmad A, Sundquist K, Zöller B, Svensson PJ, Sundquist J, Memon AA.

J Thromb Thrombolysis. 2016 Jul;42(1):135-41. doi: 10.1007/s11239-015-1328-x.

PMID:
26743062
10.

Association between TLR9 rs5743836 polymorphism and risk of recurrent venous thromboembolism.

Ahmad A, Sundquist K, Zöller B, Svensson PJ, Sundquist J, Memon AA.

J Thromb Thrombolysis. 2017 Jul;44(1):130-138. doi: 10.1007/s11239-017-1491-3.

11.

Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members.

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group.

Genet Med. 2011 Jan;13(1):67-76. doi: 10.1097/GIM.0b013e3181fbe46f.

PMID:
21150787
12.

Sex-specific risk factors for recurrent venous thromboembolism.

Olié V, Zhu T, Martinez I, Scarabin PY, Emmerich J.

Thromb Res. 2012 Jul;130(1):16-20. doi: 10.1016/j.thromres.2011.10.026. Epub 2011 Nov 17.

PMID:
22100316
13.

Genetic Risk Factors of Venous Thromboembolism in the East Algerian Population.

Moussaoui S, Saussoy P, Ambroise J, Defour JP, Zouitene R, Sifi K, Abadi N.

Clin Appl Thromb Hemost. 2017 Mar;23(2):105-115. doi: 10.1177/1076029615600789. Epub 2016 Jul 10.

PMID:
26304686
14.

A genome-wide association study in the genetic analysis of idiopathic thrombophilia project suggests sex-specific regulation of mitochondrial DNA levels.

López S, Buil A, Souto JC, Casademont J, Martinez-Perez A, Almasy L, Soria JM.

Mitochondrion. 2014 Sep;18:34-40. doi: 10.1016/j.mito.2014.09.004. Epub 2014 Sep 18.

PMID:
25240745
15.

Risk prediction of recurrent venous thromboembolism: a multiple genetic risk model.

Ahmad A, Sundquist K, Palmér K, Svensson PJ, Sundquist J, Memon AA.

J Thromb Thrombolysis. 2019 Feb;47(2):216-226. doi: 10.1007/s11239-018-1762-7.

16.

Identification of Genetic Aberrations in Thrombomodulin Gene in Patients With Recurrent Venous Thromboembolism.

Ahmad A, Sundquist K, Zöller B, Svensson PJ, Sundquist J, Memon AA.

Clin Appl Thromb Hemost. 2017 May;23(4):319-328. doi: 10.1177/1076029616686716. Epub 2017 Jan 4.

PMID:
28049360
17.

Homozygous factor V Leiden and double heterozygosity for factor V Leiden and prothrombin mutation.

Saemundsson Y, Sveinsdottir SV, Svantesson H, Svensson PJ.

J Thromb Thrombolysis. 2013 Oct;36(3):324-31. doi: 10.1007/s11239-012-0824-5.

PMID:
23054468
18.

Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden.

Couturaud F, Kearon C, Leroyer C, Mercier B, Abgrall JF, Le Gal G, Lacut K, Oger E, Bressollette L, Ferec C, Lamure M, Mottier D; Groupe d'Etude de la Thrombose de Bretagne Occidentale (G.E.T.B.O).

Thromb Haemost. 2006 Dec;96(6):744-9.

PMID:
17139368
19.

Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms.

Bucciarelli P, De Stefano V, Passamonti SM, Tormene D, Legnani C, Rossi E, Castaman G, Simioni P, Cini M, Martinelli I.

Blood. 2013 Oct 10;122(15):2555-61. doi: 10.1182/blood-2013-05-503649. Epub 2013 Aug 2.

20.

Identification of polymorphisms in Apolipoprotein M gene and their relationship with risk of recurrent venous thromboembolism.

Ahmad A, Sundquist K, Zöller B, Dahlbäck B, Svensson PJ, Sundquist J, Memon AA.

Thromb Haemost. 2016 Aug 30;116(3):432-41. doi: 10.1160/TH16-03-0178. Epub 2016 Jun 9.

PMID:
27277397

Supplemental Content

Support Center